Werbung
Anlageziel
Carnegie Medical is a Sub Fund of the CARNEGIE FUND, an unincorporated open-ended collective investment fund registered in Luxembourg under Part 1 of the Law of December 20, 2002. The investment objective of the Sub Fund is to achieve long-term capital growth through global investment in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors. The Sub Fund will focus particularly on large-cap companies which will account for at least 75% of the Sub Fund?s value and also on small-cap companies which may represent up to 25% of the Sub Fund?s value.
Stammdaten
Name | C WorldWide Medical 2A Fonds |
ISIN | LU0121135528 |
WKN | |
Fondsgesellschaft | C WorldWide Fund Management S.A. |
Benchmark | MSCI World/Health Care |
Ausschüttungsart | Thesaurierend |
Manager | Mikael Svensson, Ulf Arvidsson |
Domizil | Luxembourg |
Fondskategorie | Aktien |
Auflagedatum | 18.12.2000 |
Geschäftsjahr | 31.12. |
VL-fähig? | Nein |
Depotbank | Bank of New York Mellon (Luxembourg) S.A. |
Zahlstelle | UBS Fund Services (Lux) SA |
Riester Fonds | Nein |
Basisdaten
Auflagedatum | 18.12.2000 |
Depotbank | Bank of New York Mellon (Luxembourg) S.A. |
Zahlstelle | UBS Fund Services (Lux) SA |
Domizil | Luxembourg |
Geschäftsjahr | 31.12. |
Aktuelle Daten
Morningstar Rating | |
Aktueller Rücknahmepreis | 2.270,59 |
Anzahl Fonds der Kategorie | 781 |
Volumen der Tranche | 9,15 Mio. NOK |
Fonds Volumen | 777,10 Mio. NOK |
Total Expense Ratio (TER) | 0,72 |
Gebühren
Laufende Kosten | 0,80% |
Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 0,72% |
Transaktionskosten | 0,08% |
Depotbankgebühr | - |
Managementgebühr | 1,50% |
Rücknahmegebühr | - |
Ausgabeaufschlag | 3,00% |
Performancedaten
Veränderung Vortag | 8,96 |
WE seit Jahresbeginn | 16,41% |